'Safe Harbor' For Preapproval Information Exchange To Get Legislative Push
Executive Summary
US Academy of Managed Care Pharmacy is developing language to protect exchange of clinical and economic information on pipeline products between manufacturers and healthcare decision-makers; safe harbor could find a home in legislation reauthorizing FDA user fee programs.
You may also be interested in...
Off-Label Communications Bill Allowing Discussion Of Unapproved Drugs Advances
Safe harbor for off label discussions between manufacturers and payers clears US House Energy & Commerce Health Subcommittee. Bill covers unapproved drugs as well as off label uses for approved agents.
Off-Label Communications: Legislative Reform Efforts Struggle, But Continue
At hearing, House Energy & Commerce Committee leadership supports legislation to provide clarity and more latitude in off-label communications at hearing but Democrats oppose broad change.
Pharmacoeconomic Communications To Payers Getting Multiple Pilots By Genentech
Bristol, Genentech execs describe how their companies are adapting to US FDA loosening some restrictions on how sponsors can talk about data that are 'related to' approved indications.